ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2023

Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009-2022.

Ryosuke Kuribayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.